Coinstar, Inc. (NASDAQ:CSTR) will report financial results for the 2011 second quarter on Thursday, July 28, 2011, after the market close. Coinstar's Chief Executive Officer Paul Davis and Chief Financial Officer J. Scott Di Valerio will host a conference call at 2:00 p.m. PDT (5:00 p.m. EDT) to review the results. The conference call will be webcast live and archived on the Investor Relations section of Coinstar's website at www.coinstarinc.com.

Coinstar, Inc., through its subsidiaries, provides automated retail solutions primarily in the United States, Canada, Puerto Rico, the United Kingdom, and Ireland.

****************************************

POWER 3 MEDICAL (PWRM)
Breast cancer is the one of the commonest malignancies afflicting women. In some parts it is the most common malignancy. It is currently estimated that one in 14 of all female children born will develop breast cancer in their lifetime.

Despite extensive investigation into the cause of breast cancer there is still no known cause. However, a combination of environmental factors and genetic mutations are thought to be responsible for this cancer. In familial breast cancers, a molecular change in the genes BRCA1 and BRCA2 play a major role in the onset of the disease.

Breast cancer is mainly of two types:

Ductal carcinoma- occurs in milk ducts
Lobular carcinoma- occurs in the milk secreting breast lobules

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases.

Power 3 Medical Products' BC-SeraPro is a blood serum test designed to diagnose breast cancer in individuals. The test is based on proteomic technology in which a blood serum sample drawn from a patient will monitor the concentration of each protein biomarker residing in a panel of blood serum protein biomarkers to determine if a patient has breast cancer. The biomarkers in the panel have been selected for their ability to discriminate breast cancer patients from non-cancerous patients.

For more information please visit official website of PWRM:http://www.power3medical.com.

****************************************

ShoreTel Inc., (NASDAQ:SHOR) announced that it will welcome leading business communications experts, including resellers, technology partners and industry analysts, to connect and collaborate at the annual ShoreTel Champion Partner Conference (Twitter: #SHOR11), July 19-21 in Chicago, Ill. ShoreTel and partners from around the globe will share insights and best practices, and learn about new market opportunities for IP telephony and unified communications.

ShoreTel, Inc., together with its subsidiaries, provides Internet protocol (IP) telecommunications systems for enterprises in the United States.

****************************************

SuperGen, Inc. (NASDAQ:SUPG) announced that its chairman, president and chief executive officer, James S.J. Manuso, Ph.D., has been elected to the Full Board of Directors of the Biotechnology Industry Organization (BIO) at its 2011 International Convention. "I was honored to serve on the BIO Board of Directors," said Dr. Manuso. "Collaborating with such an esteemed group of international life sciences leaders on health policy affecting oncology patients and those with other serious illnesses will hopefully enhance the effectiveness with which medical therapies are discovered, approved, and delivered."

Supergen, Inc., a pharmaceutical company, primarily engages in the discovery and development of therapies to treat patients with cancer.

****************************************

China BAK Battery, Inc. (NASDAQ:CBAK) announced that the Company's Shenzhen production facility successfully passed an audit conducted by Samsung, a prerequisite for the use of the Company's prismatic lithium ion battery cells in Samsung cell phones. In May 2011, a Samsung factory audit team spent nearly twelve hours at China BAK's prismatic battery cell plant in Shenzhen. Samsung's audit focused on product quality and environmental management through a stringent and meticulous review of a number of aspects of our plant's operations, including raw materials, production process, equipment utilization, quality inspection, environmental management, and document management.

China BAK Battery, Inc., together with its subsidiaries, engages in the manufacture, commercialization, and distribution of various standard and customized lithium ion rechargeable batteries.

CRWESelect, a stock highlight publication is pleased to alert investors of stocks on the move.

Sign Up for our Free Stock Newsletter at http://www.crweselect.com/signup

*******************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).